All In MedTech

FDA Clearance Tracker · P930016-S062

iDesign Advanced WaveScan Studio, STAR Excimer Laser System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 26, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 26, 2021

Approved

Time to decision

148 days

Received Oct 1, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P930016-S062
Device name
iDesign Advanced WaveScan Studio, STAR Excimer Laser System
Applicant location
Milpitas, CA
Received
Oct 1, 2020
Decided
Feb 26, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P930016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

Approval of several minor clarifications and corrections to either define the original intent of the protocol, or correct mismatched information in the protocol

Source documents

Other decisions for Amo Manufacturing USA, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.